Autor: "Liu, Albert Y" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: The importance of PrEP persistence in preventing HIV infections on PrEP.
Autorzy:: Spinelli MA; Division of HIV, ID, and Global Medicine, University of California, San Francisco, CA, USA.; San Francisco Department of Public Health, San Francisco, CA, USA.
Laborde N; San Francisco Department of Public Health, San Francisco, CA, USA.
Kinley P; San Francisco Department of Public Health, San Francisco, CA, USA.
Whitacre R; Department of Anthropology and Sociology, The Graduate Institute Geneva, Geneva, Switzerland.
Scott HM; San Francisco Department of Public Health, San Francisco, CA, USA.
Walker N; San Francisco Department of Public Health, San Francisco, CA, USA.
Liu AY; San Francisco Department of Public Health, San Francisco, CA, USA.
Gandhi M; Division of HIV, ID, and Global Medicine, University of California, San Francisco, CA, USA.
Buchbinder SP; San Francisco Department of Public Health, San Francisco, CA, USA.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2020 Aug; Vol. 23 (8), pp. e25578.
Typ publikacji:: Letter; Research Support, N.I.H., Extramural; Comment
MeSH Terms:: Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Infections*/prevention & control
Pre-Exposure Prophylaxis*
Humans ; Medication Adherence ; San Francisco ; United States

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Missed opportunities to prevent HIV infections among pre-exposure prophylaxis users: a population-based mixed methods study, San Francisco, United States.
Autorzy:: Spinelli MA; University of California, San Francisco, Division of HIV, ID, and Global Medicine, San Francisco, CA, USA.; San Francisco Department of Public Health, San Francisco, CA, USA.
Laborde N; San Francisco Department of Public Health, San Francisco, CA, USA.
Kinley P; San Francisco Department of Public Health, San Francisco, CA, USA.
Whitacre R; Graduate Institute of International and Development Studies, Department of Sociology and Anthropology, Geneve, Switzerland.
Scott HM; San Francisco Department of Public Health, San Francisco, CA, USA.
Walker N; San Francisco Department of Public Health, San Francisco, CA, USA.
Liu AY; San Francisco Department of Public Health, San Francisco, CA, USA.
Gandhi M; University of California, San Francisco, Division of HIV, ID, and Global Medicine, San Francisco, CA, USA.
Buchbinder SP; San Francisco Department of Public Health, San Francisco, CA, USA.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2020 Apr; Vol. 23 (4), pp. e25472.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Pre-Exposure Prophylaxis*/methods
HIV Infections/*prevention & control
Adult ; Aged ; Anti-HIV Agents/therapeutic use ; Cohort Studies ; Female ; HIV Infections/epidemiology ; HIV Infections/transmission ; Homosexuality, Male ; Humans ; Incidence ; Male ; Middle Aged ; San Francisco/epidemiology ; Substance-Related Disorders ; United States ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study.
Autorzy:: Marins LMS; Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas (INI/Fiocruz), Rio de Janeiro, Brazil.
Torres TS; Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas (INI/Fiocruz), Rio de Janeiro, Brazil.
Leite IDC; Fundação Oswaldo Cruz, Escola Nacional de Saúde Pública (ENSP/Fiocruz), Rio de Janeiro, Brazil.
Moreira RI; Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas (INI/Fiocruz), Rio de Janeiro, Brazil.
Luz PM; Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas (INI/Fiocruz), Rio de Janeiro, Brazil.
Hoagland B; Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas (INI/Fiocruz), Rio de Janeiro, Brazil.
Kallas EG; Universidade de São Paulo, Escola de Medicina, São Paulo, Brazil.
Madruga JV; Centro de Referência e Treinamento em DST/AIDS, São Paulo, Brazil.
Liu AY; San Francisco Department of Public Health, Bridge HIV, San Francisco, California, United States of America.
Anderson PL; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, United States of America.
Grinsztejn B; Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas (INI/Fiocruz), Rio de Janeiro, Brazil.
Veloso VG; Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas (INI/Fiocruz), Rio de Janeiro, Brazil.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2019 Aug 20; Vol. 14 (8), pp. e0221281. Date of Electronic Publication: 2019 Aug 20 (Print Publication: 2019).
Typ publikacji:: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/*therapeutic use
HIV Infections/*prevention & control
Medication Adherence/*statistics & numerical data
Pre-Exposure Prophylaxis/*statistics & numerical data
Sexual and Gender Minorities/*statistics & numerical data
Transgender Persons/*statistics & numerical data
Adolescent ; Adult ; Anti-HIV Agents ; Brazil ; Dried Blood Spot Testing ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/blood ; Feasibility Studies ; Female ; Humans ; Male ; Pre-Exposure Prophylaxis/methods ; Prospective Studies ; Self Report/statistics & numerical data ; Treatment Outcome ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Pre-exposure prophylaxis for HIV prevention preferences among young adult African American men who have sex with men.
Autorzy:: Patel RR; Division of Infectious Diseases, Washington University in St. Louis, St. Louis, Missouri, United States of America.
Crane JS; Division of Infectious Diseases, Washington University in St. Louis, St. Louis, Missouri, United States of America.
López J; Department of Obstetrics and Gynecology, Washington University in St. Louis, St. Louis, Missouri, United States of America.
Chan PA; Division of Infectious Diseases, Brown University, Providence, Rhode Island, United States of America.
Liu AY; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.; Bridge HIV, San Francisco Department of Public Health, San Francisco, California, United States of America.
Tooba R; Washington University School of Medicine, Washington University in St. Louis, St. Louis, Missouri, United States of America.
James AS; Division of Public Health Sciences, Washington University in St. Louis, St. Louis, Missouri, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2018 Dec 28; Vol. 13 (12), pp. e0209484. Date of Electronic Publication: 2018 Dec 28 (Print Publication: 2018).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Black or African American/*psychology
HIV Infections/*prevention & control
Patient Preference/*statistics & numerical data
Pre-Exposure Prophylaxis/*methods
Sexual and Gender Minorities/*psychology
Administration, Oral ; Adult ; Black or African American/statistics & numerical data ; Anti-HIV Agents/administration & dosage ; HIV Infections/transmission ; Humans ; Male ; Medication Adherence/statistics & numerical data ; Missouri ; Pre-Exposure Prophylaxis/statistics & numerical data ; Sexual and Gender Minorities/statistics & numerical data ; Time Factors ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial.
Autorzy:: Baxi SM; Department of Medicine, University of California, San Francisco, California, United States of America.; School of Public Health, Division of Epidemiology, University of California, Berkeley, California, United States of America.
Vittinghoff E; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.
Bacchetti P; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.
Huang Y; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, United States of America.
Chillag K; Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Atlanta, Georgia, United States of America.
Wiegand R; Division of Parasitic Diseases and Malaria, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Anderson PL; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, United States of America.
Grant R; Department of Medicine, University of California, San Francisco, California, United States of America.; Gladstone Institutes, San Francisco, California, United States of America.; San Francisco AIDS Foundation, San Francisco, California, United States of America.
Greenblatt RM; Department of Medicine, University of California, San Francisco, California, United States of America.; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.; Department of Clinical Pharmacy, University of California, San Francisco, California, United States of America.
Buchbinder S; Department of Medicine, University of California, San Francisco, California, United States of America.; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.; San Francisco Department of Public Health, San Francisco, California, United States of America.
Gandhi M; Department of Medicine, University of California, San Francisco, California, United States of America.
Liu AY; Department of Medicine, University of California, San Francisco, California, United States of America.; San Francisco Department of Public Health, San Francisco, California, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2018 Jan 09; Vol. 13 (1), pp. e0190118. Date of Electronic Publication: 2018 Jan 09 (Print Publication: 2018).
Typ publikacji:: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Pre-Exposure Prophylaxis*
Anti-HIV Agents/*therapeutic use
Tenofovir/*therapeutic use
Placebos ; United States

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.
Autorzy:: Hoagland B; FIOCRUZ, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.
Moreira RI; FIOCRUZ, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.
De Boni RB; FIOCRUZ, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.
Kallas EG; School of Medicine, Universidade de São Paulo, Brazil.
Madruga JV; School of Medicine, Universidade de São Paulo, São Paulo, Brazil.
Vasconcelos R; School of Medicine, Universidade de São Paulo, Brazil.
Goulart S; School of Medicine, Universidade de São Paulo, São Paulo, Brazil.
Torres TS; FIOCRUZ, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.
Marins LMS; FIOCRUZ, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.
Anderson PL; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver, Aurora, CO, USA.
Luz PM; FIOCRUZ, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.
Costa Leite ID; FIOCRUZ, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.
Liu AY; San Francisco Department of Public Health, Bridge HIV, San Francisco, CA, USA.
Veloso VG; FIOCRUZ, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.
Grinsztejn B; FIOCRUZ, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.; Pokaż więcej
Corporate Authors:: PrEP Brasil Study TeamClinical Trial Number 01989611
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2017 Apr 06; Vol. 20 (1), pp. 21472.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Homosexuality, Male*
Medication Adherence*
Pre-Exposure Prophylaxis*
Transgender Persons*
Anti-HIV Agents/*therapeutic use
Emtricitabine/*therapeutic use
HIV Infections/*prevention & control
Tenofovir/*therapeutic use
Adolescent ; Adult ; Brazil ; Female ; HIV Infections/drug therapy ; Humans ; Longitudinal Studies ; Male ; Prospective Studies ; Sexual Behavior ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Phase 1 randomized pharmacokinetic and safety study of a 90‐day tenofovir vaginal ring in the United States.
Autorzy:: Liu, Albert Y. (AUTHOR) albert.liu@sfdph.org
Gundacker, Holly (AUTHOR)
Richardson, Barbra (AUTHOR)
Chen, Beatrice A. (AUTHOR)
Hoesley, Craig (AUTHOR)
van der Straten, Ariane (AUTHOR)
Brown, Amanda (AUTHOR)
Beamer, May (AUTHOR)
Robinson, Jennifer (AUTHOR)
Jacobson, Cindy E. (AUTHOR)
Scheckter, Rachel (AUTHOR)
Bunge, Katherine (AUTHOR)
Schwartz, Jill (AUTHOR)
Thurman, Andrea (AUTHOR)
Piper, Jeanna M. (AUTHOR)
Marzinke, Mark A. (AUTHOR); Pokaż więcej
Źródło:: Journal of the International AIDS Society. Mar2024, Vol. 27 Issue 3, p1-11. 11p.

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: DOT Diary: Developing a Novel Mobile App Using Artificial Intelligence and an Electronic Sexual Diary to Measure and Support PrEP Adherence Among Young Men Who Have Sex with Men
Autorzy:: Liu, Albert Y.Aff1, Aff2
Laborde, Nicole D.
Coleman, Kenneth
Vittinghoff, Eric
Gonzalez, Rafael
Wilde, Gretchen
Thorne, Annie L.
Ikeguchi, Ed
Shafner, Laura
Sunshine, Lauren
van der Straten, ArianeAff2, Aff7
Siegler, Aaron J.
Buchbinder, SusanAff1, Aff2, Aff4; Pokaż więcej
Źródło:: AIDS and Behavior. 25(4):1001-1012

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 9.

Tytuł:: Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States.
Autorzy:: Liu, Albert Y (AUTHOR) albert.liu@sfdph.org
Dominguez Islas, Clara (AUTHOR)
Gundacker, Holly (AUTHOR)
Neradilek, Blazej (AUTHOR)
Hoesley, Craig (AUTHOR)
van der Straten, Ariane (AUTHOR)
Hendrix, Craig W (AUTHOR)
Beamer, May (AUTHOR)
Jacobson, Cindy E (AUTHOR)
McClure, Tara (AUTHOR)
Harrell, Tanya (AUTHOR)
Bunge, Katherine (AUTHOR)
Devlin, Brid (AUTHOR)
Nuttall, Jeremy (AUTHOR)
Spence, Patrick (AUTHOR)
Steytler, John (AUTHOR)
Piper, Jeanna M (AUTHOR)
Marzinke, Mark A (AUTHOR); Pokaż więcej
Źródło:: Journal of the International AIDS Society. Jun2021, Vol. 24 Issue 6, p1-10. 10p. 1 Diagram, 3 Charts, 2 Graphs.

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Awareness and Willingness to Use Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men and Transgender Women in Brazil
Autorzy:: Hoagland, Brenda
De Boni, Raquel B.
Moreira, Ronaldo I.
Madruga, José Valdez
Kallas, Esper G.
Goulart, Silvia Pereira
Cerqueira, Natalia
Torres, Thiago S.
Luz, Paula M.
Fernandes, Nilo Martinez
Liu, Albert Y.
Grinsztejn, Beatriz
Veloso, Valdilea G.
Castro, Cristiane
Bertevello, Daniel
Waite, Daniel
Mizuno, Gustavo
Leite, Iuri
Granjeiro, José Roberto
Freitas, Josias
Villela, Larissa
Monteiro, Laylla
Marins, Luana
de Freitas, Lucilene A.
de Lima e Menezes, Priscilla
Vasconcelos, Ricardo
Nogueira, Roberta Schiavon
Nazer, Sandro
Porto, Tiago
Araújo, Toni
Adão, Valvina Madeira
For the PrEP Brasil Study Team; Pokaż więcej
Źródło:: AIDS and Behavior. May 2017 21(5):1278-1287

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 11.

Tytuł:: Randomized Controlled Trial of Automated Directly Observed Therapy for Measurement and Support of PrEP Adherence Among Young Men Who have Sex with Men.
Autorzy:: Buchbinder, Susan P.
Siegler, Aaron J.
Coleman, Kenneth
Vittinghoff, Eric
Wilde, Gretchen
Lockard, Annie
Scott, Hyman
Anderson, Peter L.
Laborde, Nicole
van der Straten, Ariane
Christie, Richard H.
Marlborough, Michelle
Liu, Albert Y.; Pokaż więcej
Temat:: CLINICAL drug trials
HIV prevention
EVALUATION of medical care
DIRECTLY observed therapy
HEALTH care reminder systems
MOBILE apps
TENOFOVIR
SELF-evaluation
ARTIFICIAL intelligence
PRE-exposure prophylaxis
DIARY (Literary form)
RANDOMIZED controlled trials
DESCRIPTIVE statistics
RESEARCH funding
MEN who have sex with men
PATIENT compliance
STATISTICAL sampling
EMTRICITABINE
Źródło:: AIDS & Behavior; Feb2023, Vol. 27 Issue 2, p719-732, 14p, 1 Diagram, 4 Charts, 3 Graphs
Terminy geograficzne:: CALIFORNIA
GEORGIA

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 12.

Tytuł:: Sexual Behavior, Risk Compensation, and HIV Prevention Strategies Among Participants in the San Francisco PrEP Demonstration Project: A Qualitative Analysis of Counseling Notes
Autorzy:: Carlo Hojilla, J.
Koester, Kimberly A.
Cohen, Stephanie E.
Buchbinder, Susan
Ladzekpo, Deawodi
Matheson, Tim
Liu, Albert Y.; Pokaż więcej
Źródło:: AIDS and Behavior. July 2016 20(7):1461-1469